Literature DB >> 25329043

Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair.

Olalla Iglesias-García1, Sven Baumgartner, Laura Macrí-Pellizzeri, Juan Roberto Rodriguez-Madoz, Gloria Abizanda, Elizabeth Guruceaga, Edurne Albiasu, David Corbacho, Carolina Benavides-Vallve, Mario Soriano-Navarro, Susana González-Granero, Juan José Gavira, Benjamin Krausgrill, Moises Rodriguez-Mañero, Jose Manuel García-Verdugo, Carlos Ortiz-de-Solorzano, Marcel Halbach, Juergen Hescheler, Beatriz Pelacho, Felipe Prósper.   

Abstract

Stem cell-derived cardiomyocytes (CMs) are often electrophysiologically immature and heterogeneous, which represents a major barrier to their in vitro and in vivo application. Therefore, the purpose of this study was to examine whether Neuregulin-1β (NRG-1β) treatment could enhance in vitro generation of mature "working-type" CMs from induced pluripotent stem (iPS) cells and assess the regenerative effects of these CMs on cardiac tissue after acute myocardial infarction (AMI). With that purpose, adult mouse fibroblast-derived iPS from α-MHC-GFP mice were derived and differentiated into CMs through NRG-1β and/or dimethyl sulfoxide (DMSO) treatment. Cardiac specification and maturation of the iPS was analyzed by gene expression array, quantitative real-time polymerase chain reaction, immunofluorescence, electron microscopy, and patch-clamp techniques. In vivo, the iPS-derived CMs or culture medium control were injected into the peri-infarct region of hearts after coronary artery ligation, and functional and histology changes were assessed from 1 to 8 weeks post-transplantation. On differentiation, the iPS displayed early and robust in vitro cardiogenesis, expressing cardiac-specific genes and proteins. More importantly, electrophysiological studies demonstrated that a more mature ventricular-like cardiac phenotype was achieved when cells were treated with NRG-1β and DMSO compared with DMSO alone. Furthermore, in vivo studies demonstrated that iPS-derived CMs were able to engraft and electromechanically couple to heart tissue, ultimately preserving cardiac function and inducing adequate heart tissue remodeling. In conclusion, we have demonstrated that combined treatment with NRG-1β and DMSO leads to efficient differentiation of iPS into ventricular-like cardiac cells with a higher degree of maturation, which are capable of preserving cardiac function and tissue viability when transplanted into a mouse model of AMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25329043      PMCID: PMC4313422          DOI: 10.1089/scd.2014.0211

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  54 in total

Review 1.  Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.

Authors:  Olalla Iglesias-García; Beatriz Pelacho; Felipe Prósper
Journal:  J Mol Cell Cardiol       Date:  2013-04-30       Impact factor: 5.000

2.  Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA.

Authors:  Maoyun Sun; Xinhua Yan; Yun Bian; Anthony O Caggiano; James P Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-30       Impact factor: 4.249

3.  Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Marcel Halbach; Gabriel Peinkofer; Sven Baumgartner; Martina Maass; Mirjam Wiedey; Klaus Neef; Benjamin Krausgrill; Dennis Ladage; Azra Fatima; Tomo Saric; Jürgen Hescheler; Jochen Müller-Ehmsen
Journal:  Cardiovasc Res       Date:  2013-09-16       Impact factor: 10.787

4.  Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.

Authors:  Masashi Kawamura; Shigeru Miyagawa; Kenji Miki; Atsuhiro Saito; Satsuki Fukushima; Takahiro Higuchi; Takuji Kawamura; Toru Kuratani; Takashi Daimon; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

Review 5.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

6.  A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.

Authors:  Elizabeth M Winter; Angelique A M van Oorschot; Bianca Hogers; Linda M van der Graaf; Pieter A Doevendans; Robert E Poelmann; Douwe E Atsma; Adriana C Gittenberger-de Groot; Marie Jose Goumans
Journal:  Circ Heart Fail       Date:  2009-08-06       Impact factor: 8.790

7.  Gene Ontology annotations and resources.

Authors:  J A Blake; M Dolan; H Drabkin; D P Hill; Ni Li; D Sitnikov; S Bridges; S Burgess; T Buza; F McCarthy; D Peddinti; L Pillai; S Carbon; H Dietze; A Ireland; S E Lewis; C J Mungall; P Gaudet; R L Chrisholm; P Fey; W A Kibbe; S Basu; D A Siegele; B K McIntosh; D P Renfro; A E Zweifel; J C Hu; N H Brown; S Tweedie; Y Alam-Faruque; R Apweiler; A Auchinchloss; K Axelsen; B Bely; M -C Blatter; C Bonilla; L Bouguerleret; E Boutet; L Breuza; A Bridge; W M Chan; G Chavali; E Coudert; E Dimmer; A Estreicher; L Famiglietti; M Feuermann; A Gos; N Gruaz-Gumowski; R Hieta; C Hinz; C Hulo; R Huntley; J James; F Jungo; G Keller; K Laiho; D Legge; P Lemercier; D Lieberherr; M Magrane; M J Martin; P Masson; P Mutowo-Muellenet; C O'Donovan; I Pedruzzi; K Pichler; D Poggioli; P Porras Millán; S Poux; C Rivoire; B Roechert; T Sawford; M Schneider; A Stutz; S Sundaram; M Tognolli; I Xenarios; R Foulgar; J Lomax; P Roncaglia; V K Khodiyar; R C Lovering; P J Talmud; M Chibucos; M Gwinn Giglio; H -Y Chang; S Hunter; C McAnulla; A Mitchell; A Sangrador; R Stephan; M A Harris; S G Oliver; K Rutherford; V Wood; J Bahler; A Lock; P J Kersey; D M McDowall; D M Staines; M Dwinell; M Shimoyama; S Laulederkind; T Hayman; S -J Wang; V Petri; T Lowry; P D'Eustachio; L Matthews; R Balakrishnan; G Binkley; J M Cherry; M C Costanzo; S S Dwight; S R Engel; D G Fisk; B C Hitz; E L Hong; K Karra; S R Miyasato; R S Nash; J Park; M S Skrzypek; S Weng; E D Wong; T Z Berardini; E Huala; H Mi; P D Thomas; J Chan; R Kishore; P Sternberg; K Van Auken; D Howe; M Westerfield
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

8.  Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.

Authors:  Hideki Uosaki; Hiroyuki Fukushima; Ayako Takeuchi; Satoshi Matsuoka; Norio Nakatsuji; Shinya Yamanaka; Jun K Yamashita
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

9.  New strategies for echocardiographic evaluation of left ventricular function in a mouse model of long-term myocardial infarction.

Authors:  Carolina Benavides-Vallve; David Corbacho; Olalla Iglesias-Garcia; Beatriz Pelacho; Edurne Albiasu; Sara Castaño; Arrate Muñoz-Barrutia; Felipe Prosper; Carlos Ortiz-de-Solorzano
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.

Authors:  Yuji Shiba; Sarah Fernandes; Wei-Zhong Zhu; Dominic Filice; Veronica Muskheli; Jonathan Kim; Nathan J Palpant; Jay Gantz; Kara White Moyes; Hans Reinecke; Benjamin Van Biber; Todd Dardas; John L Mignone; Atsushi Izawa; Ramy Hanna; Mohan Viswanathan; Joseph D Gold; Michael I Kotlikoff; Narine Sarvazyan; Matthew W Kay; Charles E Murry; Michael A Laflamme
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

View more
  14 in total

Review 1.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

2.  Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation.

Authors:  Kaitlin K Dunn; Isabella M Reichardt; Aaron D Simmons; Gyuhyung Jin; Martha E Floy; Kelsey M Hoon; Sean P Palecek
Journal:  Biotechnol J       Date:  2019-05-14       Impact factor: 4.677

Review 3.  Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration.

Authors:  Jan Aam Kamps; Guido Krenning
Journal:  World J Cardiol       Date:  2016-02-26

Review 4.  The Potential of Stem Cells and Stem Cell-Derived Exosomes in Treating Cardiovascular Diseases.

Authors:  Jing Ni; Yuxi Sun; Zheng Liu
Journal:  J Cardiovasc Transl Res       Date:  2018-03-10       Impact factor: 4.132

Review 5.  Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.

Authors:  Matthew E Hartman; Dao-Fu Dai; Michael A Laflamme
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

Review 6.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

Review 7.  Novel Biological Therapies Targeting Heart Failure: Myocardial Rejuvenation.

Authors:  Amanda J Favreau-Lessard; Sergey Ryzhov; Douglas B Sawyer
Journal:  Heart Fail Clin       Date:  2016-05-10       Impact factor: 3.179

8.  Engineering aligned human cardiac muscle using developmentally inspired fibronectin micropatterns.

Authors:  Ivan Batalov; Quentin Jallerat; Sean Kim; Jacqueline Bliley; Adam W Feinberg
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.996

Review 9.  Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Peng Wu; Gang Deng; Xiyalatu Sai; Huiming Guo; Huanlei Huang; Ping Zhu
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 10.  Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.

Authors:  Kaitlin K Dunn; Sean P Palecek
Journal:  Front Med (Lausanne)       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.